Holdings of iShares U.S. Pharmaceuticals ETF
iShares Trust · 56 declared positions · as of Mar 31, 2026
Original filing · Net assets 1B $ · Ten largest lines: 78.3 % of the equity sleeve
Country breakdown
Shares computed on the equity sleeve, the only part this site carries.
| Country | Lines | Value (USD) | Share |
|---|---|---|---|
| US | 52 | 955.2M $ | 95.56 % |
| IE | 2 | 36.2M $ | 3.63 % |
| CA | 1 | 5.2M $ | 0.52 % |
| SG | 1 | 2.9M $ | 0.29 % |
Sector breakdown is published in no regulatory filing: neither Form N-PORT nor the LEI reference data carries an activity code. It is absent rather than estimated.
Positions
| Company | Shares | Value (USD) | Weight |
|---|---|---|---|
| Johnson & Johnson | 942,632 | 230.4M $ | 23.03 % |
| Eli Lilly & Co | 229,087 | 210.7M $ | 21.06 % |
| Merck & Co Inc | 394,200 | 47.4M $ | 4.74 % |
| Pfizer Inc | 1,678,022 | 47.1M $ | 4.71 % |
| Royalty Pharma PLC | 981,152 | 47.1M $ | 4.70 % |
| Bristol-Myers Squibb Co | 763,754 | 46.3M $ | 4.63 % |
| Zoetis Inc | 382,419 | 45.2M $ | 4.52 % |
| Viatris Inc | 3,219,194 | 43.5M $ | 4.35 % |
| Elanco Animal Health Inc | 1,388,731 | 33.2M $ | 3.32 % |
| Jazz Pharmaceuticals PLC | 169,838 | 32.1M $ | 3.21 % |
| Axsome Therapeutics Inc | 118,359 | 20M $ | 2.00 % |
| Terns Pharmaceuticals Inc | 240,429 | 12.7M $ | 1.27 % |
| Ligand Pharmaceuticals Inc | 55,011 | 11M $ | 1.10 % |
| Indivior Pharmaceuticals Inc | 348,967 | 10.6M $ | 1.06 % |
| Corcept Therapeutics Inc | 261,660 | 10.5M $ | 1.05 % |
| Crinetics Pharmaceuticals Inc | 286,520 | 10.4M $ | 1.04 % |
| Supernus Pharmaceuticals Inc | 160,263 | 8.3M $ | 0.83 % |
| Prestige Consumer Healthcare Inc | 132,257 | 7.8M $ | 0.78 % |
| Tarsus Pharmaceuticals Inc | 109,154 | 7.7M $ | 0.77 % |
| Liquidia Corp | 192,090 | 7.2M $ | 0.72 % |
| Edgewise Therapeutics Inc | 207,131 | 6.5M $ | 0.65 % |
| Amneal Pharmaceuticals Inc | 474,468 | 5.9M $ | 0.59 % |
| Nektar Therapeutics | 78,204 | 5.6M $ | 0.56 % |
| Definium Therapeutics Inc | 275,332 | 5.2M $ | 0.52 % |
| Alumis Inc | 226,551 | 5M $ | 0.50 % |
| Enliven Therapeutics Inc | 124,406 | 4.9M $ | 0.49 % |
| Innoviva Inc | 198,530 | 4.6M $ | 0.46 % |
| Organon & Co | 726,652 | 4.4M $ | 0.44 % |
| Perrigo Co PLC | 384,659 | 4.1M $ | 0.41 % |
| Ocular Therapeutix Inc | 486,759 | 4.1M $ | 0.41 % |
| ANI Pharmaceuticals Inc | 50,247 | 3.9M $ | 0.39 % |
| Trevi Therapeutics Inc | 290,306 | 3.5M $ | 0.35 % |
| Harrow Inc | 92,131 | 3.2M $ | 0.32 % |
| Amylyx Pharmaceuticals Inc | 233,280 | 3.2M $ | 0.32 % |
| Phibro Animal Health Corp | 57,644 | 3.2M $ | 0.32 % |
| Harmony Biosciences Holdings Inc | 111,077 | 3.1M $ | 0.31 % |
| WaVe Life Sciences Ltd | 404,066 | 2.9M $ | 0.29 % |
| Collegium Pharmaceutical Inc | 88,352 | 2.9M $ | 0.29 % |
| Nuvation Bio Inc | 668,795 | 2.9M $ | 0.29 % |
| EyePoint Inc | 217,506 | 2.8M $ | 0.28 % |
| Xeris Biopharma Holdings Inc | 463,758 | 2.7M $ | 0.27 % |
| Pacira BioSciences Inc | 114,720 | 2.6M $ | 0.26 % |
| Rapport Therapeutics Inc | 79,927 | 2.5M $ | 0.25 % |
| MBX Biosciences Inc | 70,280 | 2.1M $ | 0.21 % |
| Omeros Corp | 198,165 | 2.1M $ | 0.21 % |
| Amphastar Pharmaceuticals Inc | 98,895 | 1.9M $ | 0.19 % |
| Arvinas Inc | 179,506 | 1.9M $ | 0.19 % |
| Maze Therapeutics Inc | 59,177 | 1.8M $ | 0.18 % |
| Theravance Biopharma Inc | 103,389 | 1.7M $ | 0.17 % |
| LB Pharmaceuticals Inc | 67,960 | 1.7M $ | 0.17 % |
| Phathom Pharmaceuticals Inc | 139,379 | 1.5M $ | 0.15 % |
| Septerna Inc | 63,823 | 1.5M $ | 0.15 % |
| BioAge Labs Inc | 84,022 | 1.5M $ | 0.15 % |
| CorMedix Inc | 204,800 | 1.4M $ | 0.14 % |
| Evolus Inc | 181,171 | 744.6K $ | 0.07 % |
| LENZ Therapeutics Inc | 61,219 | 560.2K $ | 0.06 % |